Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
113.4 EUR | -0.31% | +1.48% | +43.73% |
Mar. 08 | UCB Announces 48-Week Phase 3 Analyses of Pooled Phase 3 Data from the BE HEARD I and BE HEARD II Studies | CI |
Mar. 08 | UCB : UCB all set to reach new highs |
Sales 2024 * | 5.61B 6.05B | Sales 2025 * | 6.36B 6.85B | Capitalization | 21.58B 23.27B |
---|---|---|---|---|---|
Net income 2024 * | 470M 507M | Net income 2025 * | 918M 990M | EV / Sales 2024 * | 4.14 x |
Net Debt 2024 * | 1.63B 1.76B | Net Debt 2025 * | 801M 863M | EV / Sales 2025 * | 3.52 x |
P/E ratio 2024 * |
53.3
x | P/E ratio 2025 * |
25.4
x | Employees | 8,767 |
Yield 2024 * |
1.23% | Yield 2025 * |
1.28% | Free-Float | 61.42% |
Latest transcript on UCB
1 day | +0.09% | ||
1 week | +1.88% | ||
Current month | +6.90% | ||
1 month | +8.43% | ||
3 months | +44.92% | ||
6 months | +46.15% | ||
Current year | +44.30% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 11-05-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 57 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 63 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-04-27 | |
Dame Davies
BRD | Director/Board Member | 73 | 13-12-31 |
Director/Board Member | 69 | 10-04-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 2 M€ | +8.44% | ||
0.72% | 14 M€ | +5.66% | - | |
0.72% | 5 M€ | +10.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 113.4 | -0.31% | 29 891 |
24-03-27 | 113.8 | -0.66% | 299,524 |
24-03-26 | 114.5 | -0.78% | 361,607 |
24-03-25 | 115.4 | +1.01% | 455,533 |
24-03-22 | 114.2 | +2.24% | 583,140 |
Real-time Euronext Bruxelles, March 28, 2024 at 06:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.30% | 23.35B | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B | |
+1.27% | 8.71B |